GB2240476B - 5 ht-3 antagonists for the prevention or reduction of dependence - Google Patents

5 ht-3 antagonists for the prevention or reduction of dependence

Info

Publication number
GB2240476B
GB2240476B GB9104599A GB9104599A GB2240476B GB 2240476 B GB2240476 B GB 2240476B GB 9104599 A GB9104599 A GB 9104599A GB 9104599 A GB9104599 A GB 9104599A GB 2240476 B GB2240476 B GB 2240476B
Authority
GB
United Kingdom
Prior art keywords
antagonists
dependence
prevention
reduction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
GB9104599A
Other versions
GB9104599D0 (en
GB2240476A (en
Inventor
Assunta Imperato
Dietmar Roemer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB8816298A external-priority patent/GB2206788B/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of GB9104599D0 publication Critical patent/GB9104599D0/en
Publication of GB2240476A publication Critical patent/GB2240476A/en
Application granted granted Critical
Publication of GB2240476B publication Critical patent/GB2240476B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
GB9104599A 1987-07-11 1991-03-05 5 ht-3 antagonists for the prevention or reduction of dependence Expired - Lifetime GB2240476B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3722959 1987-07-11
DE3735719 1987-10-22
CH451087 1987-11-19
GB8816298A GB2206788B (en) 1987-07-11 1988-07-08 5 ht-3 antagonist for the treatment or reduction of dependence

Publications (3)

Publication Number Publication Date
GB9104599D0 GB9104599D0 (en) 1991-04-17
GB2240476A GB2240476A (en) 1991-08-07
GB2240476B true GB2240476B (en) 1992-03-18

Family

ID=27428784

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9104599A Expired - Lifetime GB2240476B (en) 1987-07-11 1991-03-05 5 ht-3 antagonists for the prevention or reduction of dependence

Country Status (1)

Country Link
GB (1) GB2240476B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994027965A1 (en) * 1993-05-26 1994-12-08 Syntex (U.S.A.) Inc. Novel 1-phenylalkanone 5-ht4 receptor ligands
AU2009303389B2 (en) 2008-10-17 2014-10-16 Wisconsin Alumni Research Foundation Method of making biologically active alpha-beta peptides

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0279114B1 (en) * 1986-11-21 1992-03-25 Glaxo Group Limited Medicaments for the treatment or prevention of the withdrawal syndrome

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0279114B1 (en) * 1986-11-21 1992-03-25 Glaxo Group Limited Medicaments for the treatment or prevention of the withdrawal syndrome

Also Published As

Publication number Publication date
GB9104599D0 (en) 1991-04-17
GB2240476A (en) 1991-08-07

Similar Documents

Publication Publication Date Title
GB2240475B (en) 5 ht-3 antagonist for the prevention or reduction of dependence
DE3277696D1 (en) Carboxylic beta-lactam compounds and the preparation thereof
HK1005448A1 (en) Imidazole compounds and blocidal compositions comprising the same
GB2178743B (en) Methods and compositions for the detection of familial hypercholestero lemia
GB8513721D0 (en) 1 24-dihydroxy-22-vitamin d3
GB8711534D0 (en) Corrosion inhibiting composition
YU65484A (en) Integrated bolt
GB8806630D0 (en) Journal
EP0180190A3 (en) 3,4-dihydrobenzopyran compounds and pharmaceutical composition containing the same
GB2198284B (en) Determining the composition of a solid body
ZA858891B (en) V1-vasopressin antagonists
GB2240476B (en) 5 ht-3 antagonists for the prevention or reduction of dependence
GB2213183B (en) Fish-plates
JPS6470495A (en) Organoboron-sulfur compound and lubricant composition containing the same
PH22634A (en) 3 substituted thiopyrones
ZA883601B (en) Vaspressin antagonists
EP0659409A3 (en) Substance 1 antagonists for the inhibition of angiogenesis.
IL88566A (en) Composition for the reduction of phlebectasiae and its preparation
ZA885123B (en) Pest-combating agents based on derivatives of 2,3-diaminomaleonitrile
GB8828950D0 (en) Anti-inflammatory and antidegenerative compounds isolated from l-681,512
CS716986A1 (en) Zapojeni stykovych obvodu systemu ims 2
PL272311A1 (en) The assembly of cumulative rails
GB8908174D0 (en) Corrosion prevention
HU912419D0 (en) Structure for the determination of geometrical shapes of railroad elements
GB8729798D0 (en) 1 5-substituted 1h-imidazoles

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19980708